Scholar Rock’s Apitegromab: A Promising Treatment for Spinal Muscular Atrophy and Obesity Scholar Rock, a clinical-stage biotech company, has recently submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for its investigational drug, apitegromab, for the treatment of patients with Spinal Muscular Atrophy (SMA). The application includes a request for…
IPC Announces Purchase of Common Shares under NCIB Toronto, March 24, 2025 – International Petroleum Corporation (IPC) is a leading independent oil and gas exploration and production company, listed on the Toronto Stock Exchange (TSX) and Nasdaq Stockholm (IPCO). IPC is dedicated to delivering sustainable energy solutions and creating value for its stakeholders. In line…
Pi Day Disappointments: The Continued Red Trend of Pi Network Ah, Pi Network. The cryptocurrency that had everyone’s hopes soaring like a hot air balloon at a county fair. But, alas, the Pi balloon has taken a nosedive, and it’s leaving a lot of us feeling like we’ve been popped. With a loss of over…
JUST (JST) Makes Its Way to Kraken: A Boost for TRON’s DeFi Ecosystem In a recent development that has sent ripples through the cryptocurrency community, JUST (JST) has been listed on the renowned cryptocurrency exchange, Kraken. This listing comes as part of Kraken’s partnership with the TRON network, and it signifies a significant expansion for…
New York Investor Alert: TELUS International (Cda) Inc. Faces Lawsuit for Potential Securities Law Violations What Happened? If you are an investor who suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment, you may have a chance to seek recovery under federal securities laws. The company is currently facing a lawsuit that alleges…
Precision BioSciences Announces New Leadership Appointments and Program Advancements DURHAM, N.C., March 24, 2023 Precision BioSciences, a pioneering clinical-stage gene editing company, has recently announced significant updates to its senior leadership team and the progression of its in vivo gene editing program, PBGENE-HBV, through a Phase 1 clinical study. The company, which utilizes its exclusive…
Class Action Lawsuit Filed Against AppLovin Corporation: What Does It Mean for Investors and the Tech Industry? On March 19, 2025, Bronstein, Gewirtz & Grossman, LLC, a renowned law firm, announced the filing of a class action lawsuit against AppLovin Corporation (“AppLovin” or “the Company”) (NASDAQ: APP) and certain of its officers. The complaint alleges…
The Best Crypto Presales To Buy Now in 2024: The Definitive List of Top Crypto Presale Coins Coinpedia Fintech News 2024 stands out as a pivotal moment for cryptocurrency enthusiasts and newcomers alike, providing a landscape ripe with opportunities for engagement and growth. Amidst this burgeoning space, the presale stage of crypto projects has garnered…
